Innovative Egg Assessment Tool From Canadian Med-Tech Startup Future Fertility Has Been Adopted For Patient Use by Trio Fertility

August 11, 2020

TORONTO, Aug. 11, 2020 /PRNewswire/ – Canadian startup company Future Fertility has commercially launched a product that is providing a new solution in the field of Assisted Reproductive Technology (ART). Their newly marketed product Violet™ is a cloud-based software that assesses the probability of an oocyte (human egg) to successfully fertilize and reach a blastocyst embryo stage. Violet™, an AI-based image technology that has been optimized through scientific collaborations with several In-Vitro Fertilization (IVF) clinics around the world, analyzes 2-D images of a patient’s eggs in real-time. Until now, there has been no accepted method to visually grade an egg or predict its reproductive potential.

> Continue reading

Related posts

February 14, 2019

IVF coverage by employers on the rise? How to know what your company offers?

Infertility coverage is the in-demand benefit of the moment for women and more companies are stepping up to offer to [...]
October 05, 2020

Graduate Student Research Internship

Canadian med-tech startup Future Fertility is looking for a graduate student for a 3-6 month internship starting immediately. At [...]
April 30, 2019

Future Fertility Launches First AI Image Analysis Tool to Evaluate Women’s Eggs

TORONTO, April 30, 2019 /CNW/ — Future Fertility Inc, an AI biotech startup focusing on reproductive innovation has developed a non-invasive image [...]